Marta Chesi

BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc

Jake Delmore, Ghayas C. Issa, Madeleine E. Lemieux et al. · Cell · 2011 · 2.8K citations · Full text

Medicine, Immunology, Therapeutic Efficacy +7

Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma

Jonathan J. Keats, Rafaël Fonseca, Marta Chesi et al. · Cancer Cell · 2007 · 980 citations · Full text

Hematological Malignancy, Medicine, Cancer Cell Biology +7

Genetics and Cytogenetics of Multiple Myeloma

Rafaël Fonseca, Bart Barlogie, Régis Bataille et al. · Cancer Research · 2004 · 685 citations

Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3

Marta Chesi, Elena Nardini, Leslie A. Brents et al. · Nature Genetics · 1997 · 646 citations · Full text

Hematological Malignancy, Frequent Translocation T, Immunology +8

Clonal competition with alternating dominance in multiple myeloma

Jonathan J. Keats, Marta Chesi, Jan B. Egan et al. · Blood · 2012 · 630 citations · Full text